The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 7 March 2013 up to and including 13 March 2013 the Company bought 16080 own shares representing 0.012% of the share capital of the Company, to the total value of BGN 36047.53 on the Bulgarian Stock Exchange. The average price per share was BGN 2.24.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3637179, representing 2.755% of the share capital of the Company.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 28 February 2013 up to and including 6 March 2013 the Company bought 7941 own shares representing 0.006% of the share capital of the Company, to the total value of BGN 17463.89 on the Bulgarian Stock Exchange. The average price per share was BGN 2.20.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3621099, representing 2.74% of the share capital of the Company.

The Board of Directors of Sopharma AD (the “Company”) notifies that for February 2013 Sopharma AD realized an increase of sales revenues of 6% compared to the same period of 2012, including 2% decrease of domestic sales and 8% increase of export sales.

During the past two months Sopharma AD recorded a decrease of sales revenues of 2%, including 2% decrease of export sales and same level of domestic sales compared to 2012.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 21 February 2013 up to and including 27 February 2013 the Company bought 29950 own shares representing 0.023% of the share capital of the Company, to the total value of BGN 64015.26 on the Bulgarian Stock Exchange. The average price per share was BGN 2.14.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3613158, representing 2.74% of the share capital of the Company.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 14 February 2012 up to and including 20 February 2013 the Company bought 9400 own shares representing 0.0071% of the share capital of the Company, to the total value of BGN 20757.75 on the Bulgarian Stock Exchange. The average price per share was BGN 2.21.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3583208, representing 2.71% of the share capital of the Company.

The Board of Directors of Sopharma AD (the “Company”) announces that the Company sold 1105000 ordinary registered shares with voting rights, representing 3.36% of the share of the capital of Sopharma Trading AD. After this transaction the share of Sopharma AD in the capital of Sopharma Trading AD decreased below 80% to 76.77%.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 7 February 2012 up to and including 13 February 2013 the Company bought 13439 own shares representing 0.0102% of the share capital of the Company, to the total value of BGN 30490.38 on the Bulgarian Stock Exchange. The average price per share was BGN 2.27.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3573808, representing 2.71% of the share capital of the Company.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 31 January 2012 up to and including 6 February 2013 the Company bought 18198 own shares representing 0.014% of the share capital of the Company, to the total value of BGN 42205.39 on the Bulgarian Stock Exchange. The average price per share was BGN 2.32.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 3560369, representing 2.697% of the share capital of the Company.

The Board of Directors of Sopharma AD (the “Company”) notifies that for January 2013 Sopharma AD realized decrease of sales revenues of 14% compared to the same period of 2012, including 3% increase of domestic sales and 19% decrease of export sales.

The Board of Directors of Sopharma AD (the “Company”) presents the Invitation and the materials for the Extraordinary General Meeting of shareholders of "Sopharma” AD, which shall take place on 28 February 2013 from 11.00 AM and, in the absence of a quorum - on 15 March 2013 from 11.00 AM in Sofia, "Iliensko shosee" No 16. The invitation has been registered in the Commercial Register under number 20130123144949.

Attachments:

1. Invitation to EGM;
2. Minutes of the meeting of the Board of Directors for the convening of EGM
3. Sample letter of attorney for EGM